REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,281,755 | -27.7% | 226,942 | -30.2% | 0.04% | -24.5% |
| Q2 2023 | $8,692,225 | +22.5% | 324,943 | -0.8% | 0.05% | +2.1% |
| Q1 2023 | $7,095,513 | +25.5% | 327,586 | +38.0% | 0.05% | +2.1% |
| Q4 2022 | $5,652,915 | +7.0% | 237,318 | -11.4% | 0.05% | -16.1% |
| Q3 2022 | $5,282,000 | +163.2% | 267,853 | +160.0% | 0.06% | +211.1% |
| Q2 2022 | $2,007,000 | -47.1% | 103,001 | -30.7% | 0.02% | -18.2% |
| Q1 2022 | $3,791,000 | -4.4% | 148,622 | -5.7% | 0.02% | +4.8% |
| Q4 2021 | $3,965,000 | +45.2% | 157,533 | +58.7% | 0.02% | +10.5% |
| Q3 2021 | $2,731,000 | +13.0% | 99,276 | +30.4% | 0.02% | +26.7% |
| Q2 2021 | $2,416,000 | -24.8% | 76,114 | +8.7% | 0.02% | -31.8% |
| Q1 2021 | $3,213,000 | +406.0% | 70,040 | +336.4% | 0.02% | +266.7% |
| Q4 2020 | $635,000 | -1.2% | 16,048 | -13.2% | 0.01% | -25.0% |
| Q3 2020 | $643,000 | – | 18,483 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |